Pharmaceutical USA-based Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has entered into a definitive agreement with Sweden-headquartered contract development and manufacturing organization Recipharm to develop TRB-1 and TRB-2, inhaled medicines for the treatment of asthma and chronic obstructive pulmonary disease (COPD). 15 July 2022